Central government Planning to regulate the e-pharmacy industry regarding misuse of data. Sources gave this information. According to a source, the health ministry is working on a policy to regulate the e-pharmacy industry market in the country and a group of ministers is in favor of shutting down e-pharmacies. He did not propose the idea in its current form. The government can take action against them. Let us tell you that many companies including Tata 1mg, Amazon, Flipkart, Netmeds, Pharmeasy, MedLife are selling medicines through app and online.
Show cause notice sent to online pharmacy
The health ministry has taken note of reported wrongdoings in this area, which raises concerns over data privacy, over-the-counter drugs and unfair pricing, the source said. The Drugs Controller General of India (DCGA) had last month issued a show cause notice to the online pharmacy asking why action should not be taken against them for selling and distributing drugs without licence.
Many companies including Tata 1mg, Amazon are under investigation
Online pharmacies including Tata 1mg, Amazon, and Flipkart were issued notices for selling and distributing drugs in violation of the provisions of the Drugs and Cosmetics Act, 1940. The DCGI said in the notice- This office has received from time to time various representations regarding sale of drugs through online, internet or other electronic platforms including various mobile applications, which are in violation of the Drugs and Cosmetics Act, 1940 and regulations thereunder. are in contravention of the provisions of Such sale includes drugs specified in Schedules H, HI and X which are permitted for retail sale only under the valid prescription of a registered medical practitioner and supplied under the supervision of a registered pharmacist.
Latest Business News